Nutrien Ltd. (FRA:N7T)
Germany · Delayed Price · Currency is EUR 59.50
+0.38 (0.64%)
At close: Jan 28, 2026
Nutrien Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 25,671 | 25,016 | 28,082 | 37,012 | 26,861 | 20,053 | |
Revenue Growth (YoY) | 0.45% | -10.92% | -24.13% | 37.79% | 33.95% | 3.82% |
Cost of Revenue | 17,631 | 17,486 | 19,608 | 21,588 | 17,452 | 14,814 |
Gross Profit | 8,040 | 7,530 | 8,474 | 15,424 | 9,409 | 5,239 |
Selling, General & Admin | 3,941 | 4,084 | 4,108 | 3,987 | 3,628 | 3,255 |
Other Operating Expenses | 720 | 816 | 827 | 1,534 | 737 | 393 |
Operating Expenses | 4,800 | 4,937 | 4,921 | 5,584 | 4,563 | 3,717 |
Operating Income | 3,240 | 2,593 | 3,553 | 9,840 | 4,846 | 1,522 |
Interest Expense | -662 | -683 | -726 | -484 | -463 | -475 |
Interest & Investment Income | 28 | 28 | 35 | 25 | 8 | 1 |
Earnings From Equity Investments | 59 | 130 | 101 | 247 | 89 | 73 |
Currency Exchange Gain (Loss) | -19 | -360 | -91 | -31 | -42 | -18 |
Other Non Operating Income (Expenses) | -60 | -60 | -97 | -96 | -7 | -33 |
EBT Excluding Unusual Items | 2,586 | 1,648 | 2,775 | 9,501 | 4,431 | 1,070 |
Merger & Restructuring Charges | -69 | -47 | -49 | -46 | -43 | -60 |
Gain (Loss) on Sale of Investments | - | - | - | 19 | - | 250 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -6 |
Asset Writedown | - | -530 | -774 | 780 | -33 | -824 |
Other Unusual Items | - | - | - | -8 | -187 | -48 |
Pretax Income | 2,513 | 1,136 | 1,952 | 10,246 | 4,168 | 382 |
Income Tax Expense | 678 | 436 | 670 | 2,559 | 989 | -77 |
Earnings From Continuing Operations | 1,835 | 700 | 1,282 | 7,687 | 3,179 | 459 |
Net Income to Company | 1,835 | 700 | 1,282 | 7,687 | 3,179 | 459 |
Minority Interest in Earnings | -26 | -26 | -24 | -27 | -26 | - |
Net Income | 1,809 | 674 | 1,258 | 7,660 | 3,153 | 459 |
Net Income to Common | 1,809 | 674 | 1,258 | 7,660 | 3,153 | 459 |
Net Income Growth | 146.79% | -46.42% | -83.58% | 142.94% | 586.93% | -53.73% |
Shares Outstanding (Basic) | 489 | 494 | 496 | 538 | 570 | 570 |
Shares Outstanding (Diluted) | 489 | 494 | 497 | 540 | 571 | 570 |
Shares Change (YoY) | -1.19% | -0.53% | -7.97% | -5.47% | 0.28% | -2.30% |
EPS (Basic) | 3.70 | 1.36 | 2.53 | 14.23 | 5.53 | 0.81 |
EPS (Diluted) | 3.70 | 1.36 | 2.53 | 14.18 | 5.52 | 0.81 |
EPS Growth | 150.34% | -46.25% | -82.16% | 156.88% | 585.08% | -52.60% |
Free Cash Flow | 2,269 | 1,536 | 2,672 | 5,857 | 2,109 | 1,900 |
Free Cash Flow Per Share | 4.64 | 3.11 | 5.38 | 10.85 | 3.69 | 3.33 |
Dividend Per Share | 2.175 | 2.160 | 2.120 | 1.920 | 1.840 | 1.800 |
Dividend Growth | 1.16% | 1.89% | 10.42% | 4.35% | 2.22% | 2.27% |
Gross Margin | 31.32% | 30.10% | 30.18% | 41.67% | 35.03% | 26.13% |
Operating Margin | 12.62% | 10.37% | 12.65% | 26.59% | 18.04% | 7.59% |
Profit Margin | 7.05% | 2.69% | 4.48% | 20.70% | 11.74% | 2.29% |
Free Cash Flow Margin | 8.84% | 6.14% | 9.52% | 15.82% | 7.85% | 9.47% |
EBITDA | 5,212 | 4,512 | 5,334 | 11,513 | 6,490 | 3,232 |
EBITDA Margin | 20.30% | 18.04% | 18.99% | 31.11% | 24.16% | 16.12% |
D&A For EBITDA | 1,972 | 1,919 | 1,781 | 1,673 | 1,644 | 1,710 |
EBIT | 3,240 | 2,593 | 3,553 | 9,840 | 4,846 | 1,522 |
EBIT Margin | 12.62% | 10.37% | 12.65% | 26.59% | 18.04% | 7.59% |
Effective Tax Rate | 26.98% | 38.38% | 34.32% | 24.98% | 23.73% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.